OQRO

Feed News

Explore

Insider trades Fund moves Congressional trades Federal contracts Screener

Yours

Watchlist Alerts Saved Ask Claude or ChatGPT

Create a free account Sign in

OQRO

Search/

Loading…

14 JAZZ shares were withheld to cover taxes or exercise cost (Director) | OQRO

Home
Insider trades
Jazz Pharmaceuticals
14 JAZZ shares were withheld to cover taxes or exercise cost (Director

Insider trades

Insider trade

14 JAZZ shares were withheld to cover taxes or exercise cost (Director)

Traded Aug 31, 2026 · Filed Sep 3, 2026

JAZJazz PharmaceuticalsJAZZ

14
Shares · @ $244.64

Why it stands out

Routine share withholding; mechanical by default.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Aug 31, 2026
Reporting period: Not applicable
Filed with the SEC: Sep 3, 2026

DirectorTax withholding

Context

Classification

tax withholding

Code F — shares delivered to pay exercise price or tax liability

Planned / mechanical clue

Tax mechanics (code F)

Only flagged when a footnote says so; never inferred

Source receipt

Record ID: 0001302443-26-000015

Ask Claude or ChatGPT about these filings. Connect OQRO in a minute, then ask things like “which insiders bought this week?”

Filed / recorded

Sep 3, 2026, 1:06 AM UTC

Added to OQRO

Oct 6, 2026, 7:59 PM UTC

Parser

form4-xml-v2

Data quality

Verified: identifiers matched exactly

Issuer

Jazz Pharmaceuticals plc

Issuer CIK

1232524

Ticker

JAZZ

Reporting person

Rick E Winningham

Relationship

Director

Security

Ordinary Shares

Table

Non-derivative (Table I)

Transaction date

Aug 31, 2026

Transaction code

Shares / units

Price per share

$244.64

Acquired / disposed

Disposed (D)

Shares owned after

9,466

Ownership form

Direct

Amendment

Footnotes from the filing

Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.

Around the same time

Neena M Patil (EVP & Chief Legal Officer) sold ~$289K of Jazz Pharmaceuticals

Scheduled in advanceFiled 3w ago

Renee D GalaPresident & CEO

Filed 4w ago

1,967Shares · @ $246.81

Traded Sep 8 · filed 3 days later

Routine share withholding; mechanical by default.

More Official record

Renee D Gala (President & CEO) sold ~$486K of Jazz Pharmaceuticals

Scheduled in advanceFiled 4w ago